Then, we investigated whether the process by which LAT2 targets mTOR activation to regulate apoptosis, glycolysis and chemosensitivity in pancreatic cancer cells was dependent on glutamine. The gene discussed is LAT2; the disease is familial pancreatic carcinoma.